Combinations VEGF(R) inhibitors and hepatocyte growth factor (c-Met) inhibitors for the treatment of cancer

摘要

This invention is in the field of pharmaceutical agents and specifically relates to compounds, compositions, uses and methods for treating cancer, by- combining VEGF(R) inhibitors and inhibitors of HGF/SF:c-Met.